10-Q/A: FutureTech II Acquisition Corp. Restates Q1 2024 Financials Due to Accounting Errors
Quarterly Report Amendment (Form 10-Q/A)
FutureTech II Acquisition Corp. files an amended quarterly report to correct accounting errors related to sponsor dues, common stock redemption, and notes payable.
Summary
- FutureTech II Acquisition Corp. has filed an amendment to its Q1 2024 report to address accounting errors.
- The restatement impacts items such as Due from Sponsor, Common Stock subject to possible redemption, the redemption price of the Common stock subject to possible redemption, accumulated deficit (capital contribution) and notes payable.
- The company had cash of $413 as of March 31, 2024, and a working capital deficit of $4,154,266.
- The company's management has identified a material weakness in its internal control over financial reporting related to the accounting of extension loans and the calculation of the redemption price.
- The company has until May 18, 2024 (or up to November 18, 2024, if extended) to complete a Business Combination.
- Net income for the three months ended March 31, 2024, was $129,577.
- The company has been notified by Nasdaq that it is not in compliance with listing rules due to minimum total holders and market value of listed securities requirements.
Sentiment
Score: 3
Explanation: The document indicates significant challenges, including a financial restatement, material weaknesses in internal control, and potential delisting from Nasdaq, leading to a negative sentiment.
Positives
- The company reported net income of $129,577 for the three months ended March 31, 2024.
- The company is actively working to address the material weakness in its internal control over financial reporting.
- The company has the option to extend the period to consummate a business combination up to November 18, 2024.
Negatives
- The company restated its Q1 2024 financials due to material accounting errors.
- The company has a significant working capital deficit of $4,154,266 as of March 31, 2024.
- The company has identified a material weakness in its internal control over financial reporting.
- The company received notices from Nasdaq regarding non-compliance with listing rules.
- The company's ability to continue as a going concern is in substantial doubt.
Risks
- The company's ability to complete a business combination by May 18, 2024 (or November 18, 2024, if extended) is uncertain.
- Failure to complete a business combination will result in mandatory liquidation and dissolution.
- The company's internal control over financial reporting is not effective due to a material weakness.
- The company faces potential delisting from Nasdaq due to non-compliance with listing rules.
- The company's ability to raise equity and debt financing may be impacted by market volatility and decreased liquidity.
Future Outlook
The company has until May 18, 2024 (or up to November 18, 2024, if extended) to complete a Business Combination, but there is uncertainty regarding its ability to do so.
Management Comments
- Management concluded that, as of March 31, 2024, the internal control over financial reporting was not effective due to a material weakness related to the accounting of the Extension Loans and related to the calculation of redemption price.
- Management is currently evaluating the impact of the COVID-19 pandemic and the military action in Ukraine on the company's financial position and ability to consummate a Business Combination.
Industry Context
The report reflects the challenges faced by SPACs in the current market, including difficulties in completing business combinations and maintaining listing compliance.
Comparison to Industry Standards
- Given the current market conditions, many SPACs are facing challenges in finding suitable targets and completing business combinations within the given timeframe.
- The restatement of financial statements and identification of material weaknesses in internal control are not uncommon among SPACs, particularly those nearing their liquidation deadline.
- The Nasdaq notices regarding non-compliance with listing rules are also a common occurrence for SPACs struggling to maintain the required number of shareholders and market capitalization.
Related Party Transactions
- The Sponsor has provided Extension Loans to the company to extend the period to consummate a business combination.
- The Sponsor is owed money due to overpayment of redemptions.
Stakeholder Impact
- Shareholders face the risk of liquidation if a business combination is not completed.
- Shareholders may experience dilution if additional shares are issued in connection with a business combination.
- The company's employees and service providers face uncertainty regarding the company's future operations.
Next Steps
- The company must complete a business combination by May 18, 2024 (or November 18, 2024, if extended).
- The company must address the material weakness in its internal control over financial reporting.
- The company must regain compliance with Nasdaq listing rules.
- The company intends to monitor its MVLS between now and the Compliance Date, and may, if appropriate, evaluate available options to resolve the deficiency under the Market Value Standard and regain compliance with the Market Value Standard.
Key Dates
| Date | Description |
|---|---|
| 2021-08-19 | Company incorporated in Delaware |
| 2022-02-14 | Registration statement for Initial Public Offering declared effective |
| 2022-02-18 | Company consummated Initial Public Offering |
| 2023-08-17 | Special meeting of stockholders held to approve extension of combination period |
| 2024-02-14 | Second special meeting of stockholders held to approve extension of combination period |
| 2024-03-31 | End of the fiscal quarterly period |
| 2024-04-18 | Company deposited $50,000 into the Trust Account, extending the period to consummate a business combination to May 18, 2024 |
| 2024-05-15 | Date as of which outstanding shares of Class A and Class B Common Stock are reported |
| 2024-05-18 | Original deadline to consummate a Business Combination |
| 2024-10-21 | Compliance Date to regain compliance with the Market Value Standard |
| 2024-11-18 | Extended deadline to consummate a Business Combination |
| 2025-01-14 | Date of signatures for the report |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.